Home News CGM users see more time in range during early weeks of COVID-19 pandemic back to News
minute read
Most people with diabetes who used continuous glucose monitoring during the first 8 weeks of the COVID-19 pandemic improved their time in range, although the benefits varied by region and socioeconomic status, according to study data.
Topics: Press Coverage
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
